Clinical Trial Update: Mechanistic Study of Ocrevus

View source ↗

Summary

Completed clinical trial update on a mechanistic study of Ocrevus (ocrelizumab) in multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrevus (ocrelizumab)

Snippet

Sponsor: University of Michigan | Conditions: Multiple Sclerosis | Status: COMPLETED